Post by
Systemtogo on Mar 21, 2017 11:29am
Yosprala prospects
I think this drug is way undervalued. Think of how many elderly people there are that need aspirin and have acid reflux. It has brilliant mass market appeal. A good management team should be able to capitalize on this easily.